Previous 10 | Next 10 |
Fulgent Genetics (FLGT) had a very good 2019, but it won't come as a surprise to realize that 2020 is going to be considerably more challenging. At the time of the Q4CC (March 10), the US was still a different place, so management did not see much impact of the coronavirus. In fact, they wer...
Medtronic Gets Patent Challenge from Axonics Medtronic Plc ( MDT ) saw a small setback as Axonics Modulation Technologies filed a petition with the United States Patents and Trademark Office against one of its patents. The petitions contest the validity of Medtronic's patent related to s...
BioNTech SE (NASDAQ: BNTX ) +55% on teaming up with Pfizer teams to develop COVID-19 vaccine. More news on: BioNTech SE, Co-Diagnostics, Inc., Neon Therapeutics, Inc., Stocks on the move, , Read more ...
Fulgent Genetics (NASDAQ: FLGT ) is up 26% premarket on the launch of Next Generation Sequencing (NGS) based test for the Coronavirus Disease (COVID-19). More news on: Fulgent Genetics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
TEMPLE CITY, Calif., March 17, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced the la...
Gainers: Tiziana Life Sciences TLSA +163% . More news on: Allied Healthcare Products, Inc., Akerna Corp., Inovio Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Fulgent Genetics, Inc. (FLGT) Q4 2019 Earnings Conference Call March 10, 2020 16:30 ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - CEO Paul Kim - CFO Brandon Perthuis - Chief Commercial Officer Conference Call Participants Presentation Operator Ladi...
Fulgent Genetics (NASDAQ: FLGT ): Q4 Non-GAAP EPS of $0.04 beats by $0.02 ; GAAP EPS of -$0.01 misses by $0.03 . More news on: Fulgent Genetics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Fourth Quarter 2019 Results : Revenue totals $8.4 million, growing 48% year over year Billable tests delivered total 13,977, growing 118% year over year Gross Margin improves more than 5 percentage points year over year; cost per test improves approximately 40% year over year GAAP l...
TEMPLE CITY, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced the pr...
News, Short Squeeze, Breakout and More Instantly...
Fulgent Genetics Inc. Company Name:
FLGT Stock Symbol:
NASDAQ Market:
Fulgent Genetics Inc. Website:
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2024 financial results be...
2024-07-01 14:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-21 15:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...